News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients Todd Neale March 01, 2022